Search
for
Sort by
Research 961–990 of 1000+
- The Flavonol Quercitrin Hinders GSK3 Activity and Potentiates the Wnt/β-Catenin Signaling Pathway
- Effects of finasteride, a 5 alpha-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women.
- Puberty in Boys: Correlation of Plasma Levels of Gonadotropins (LH, FSH), Androgens (Testosterone, Androstenedione, Dehydroepiandrosterone and Its Sulfate), Estrogens (Estrone and Estradiol) and Progestins (Progesterone and 17-Hydroxyprogesterone)
- Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men.
- Telogen Effluvium Secondary to Weight Loss and Therapy With Chorionic Gonadotropin
- Puberty induction with recombinant gonadotropin: What impact on future fertility?
- Hair Loss After Therapy with Chorionic Gonadotropin
- Infertility in Polycystic Ovary Syndrome: Focus on Low-Dose Gonadotropin Treatment
- Luteinizing Hormone and Human Chorionic Gonadotropin Decrease Type 2 5α-Reductase and Androgen Receptor Protein Levels in Women’s Skin
- New-onset androgenic alopecia following human chorionic gonadotropic diet and testosterone pellet implantation
- Ovarian and Adrenal Androgens and Their Link to High Human Chorionic Gonadotropin Levels: A Prospective Controlled Study
- Re: Clomiphene Citrate and Human Chorionic Gonadotropin are Both Effective in Restoring Testosterone in Hypogonadism: A Short-Course Randomized Study
- Alopecia Areata: Pituitary Function Assessed by Assay of Pituitary Gonadotropin in Urine11From the Section of Dermatology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota. The Mayo Foundation, Rochester, Minnesota, is a part of the Graduate School of the University of Minnesota.
- Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men
- Clinical and endocrine effects of finasteride, a 5α-reductase inhibitor, in women with idiopathic hirsutism
- Menstrual Irregularity in Women with Acromegaly
- Polycystic ovary syndrome (PCOS)
- Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies
- Normal Pubertal Development in Daughters of Women With PCOS: A Controlled Study
- The hyperandrogenic-insulin-resistant acanthosis nigricans syndrome: therapeutic response
- Prevalence of cervical insufficiency in polycystic ovarian syndrome
- Isosexual Precocious Pseudopuberty Secondary to a Testosterone-Secreting Leydig Cell Testicular Tumour: True Isosexual Development Early After Surgery*
- Choice of treatment for women with polycystic ovary syndrome
- Management of acne vulgaris with hormonal therapies in adult female patients
- Testosterone, 17 Ks, 17 beta E2 FSH-LH variations and hirsutism modifications during spironolactone therapy.
- Spontaneous fertility in a male patient with testotoxicosis despite suppression of FSH levels
- GRANULOSA‐THECA CELL TUMOR IN A ONE‐YEAR‐OLD INFANT
- Endocrinology, Brain, and Pituitary Gland
- Remarks on the Hormonal Background of the Male Equivalent of Polycystic Ovary Syndrome
- Pharmacological Profile of 9,11-Dehydrocortexolone 17α-Butyrate (CB-03-04), a New Androgen Antagonist with Antigonadotropic Activity